help button home button Am J Pathol sign up for etoc
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prinz, M.
Right arrow Articles by Aguzzi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prinz, M.
Right arrow Articles by Aguzzi, A.
(American Journal of Pathology. 2003;162:1103-1111.)
© 2003 American Society for Investigative Pathology

Oral Prion Infection Requires Normal Numbers of Peyer’s Patches but Not of Enteric Lymphocytes

Marco Prinz*, Gerhard Huber*, Andrew J. S. Macpherson{dagger}, Frank L. Heppner*, Markus Glatzel*, Hans-Pietro Eugster{ddagger}, Norbert Wagner§ and Adriano Aguzzi*

From the Institute of Neuropathology,* University Hospital of Zürich, Zürich, Switzerland; the Institute of Experimental Immunology,{dagger} University Hospital of Zürich, Zürich, Switzerland; the Institute of Internal Medicine,{ddagger} University Hospital of Zürich, Section of Clinical Immunology, Zürich, Switzerland; and the Institute of Genetics,§ University of Cologne, Cologne, Germany


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Prion pathogenesis following oral exposure is thought to involve gut-associated lymphatic tissue, which includes Peyer’s patches (PPs) and M cells. Recruitment of activated B lymphocytes to PPs requires {alpha}4ß7 integrin; PPs of ß7-/- mice are normal in number but are atrophic and almost entirely devoid of B cells. Here we report that minimal infectious dose and disease incubation after oral exposure to logarithmic dilutions of prion inoculum were similar in ß7-/- and wild-type mice, and PPs of both ß7-/- and wild-type mice contained 3–4 log LD50/g prion infectivity >=125 days after challenge. Despite marked reduction of B cells, M cells were present in ß7-/- mice. In contrast, mice deficient in both tumor necrosis factor and lymphotoxin-{alpha} (TNF{alpha}-/- x LT{alpha}-/-) or in lymphocytes (RAG-1-/-, µMT), in which numbers of PPs are reduced in number, were highly resistant to oral challenge, and their intestines were virtually devoid of prion infectivity at all times after challenge. Therefore, lymphoreticular requirements for enteric and for intraperitoneal uptake of prions differ from each other. Although susceptibility to prion infection following oral challenge correlates with the number of PPs, it is remarkably independent of the number of PP-associated lymphocytes.


Consumption of food contaminated with bovine spongiform encephalopathy (BSE) is believed to cause variant Creutzfeldt-Jakob disease (vCJD) in humans1,2 and ingestion of prions has been implicated in the transmission of other transmissible spongiform encephalopathies (TSE).3 Following experimental intragastric or oral exposure of rodents to scrapie, infectivity and/or disease-associated protease-resistant prion protein (PrPSc) accumulate rapidly in Peyer’s patches (PPs), gut-associated lymphoid tissues (GALT), and ganglia of the enteric nervous system4,5 long before they are detected in the central nervous system (CNS). Similarly, following experimental oral exposure of non-human primates or sheep to BSE, PrPSc was first detected in lymphoid tissues draining the gastrointestinal tract, long before detection in the CNS.6,7

B lymphocytes play a crucial role in peripheral prion pathogenesis: mice devoid of B lymphocytes do not develop disease after intraperitoneal exposure.8 This is possibly because B lymphocytes induce maturation of follicular dendritic cells (FDCs) by providing tumor necrosis factor-{alpha} (TNF-{alpha}) and lymphotoxin {alpha}/ß (LT{alpha}/ß) trimers to lymphoid organs.9 Early PrPSc deposition can be detected in FDCs within B cell follicles in lymphoid tissues of patients with vCJD10 and in rodents inoculated with scrapie by peripheral routes.11 In mouse spleens, mature FDCs have been shown to be crucial for both prion replication and PrPSc accumulation,12,13 although prion replication in lymph nodes can occur in the absence of mature FDCs.14 In contrast, the role of intestinal B cells in prion pathogenesis following oral challenge is still unclear.

Intestinal mucosal immunity provides an important level of defense against foreign pathogens. The ability of B and T lymphocytes to be recruited to the site of infection is critical for an effective immune response. This process is mediated by homing receptors on effector cells with cognate ligands at peripheral or mucosal sites.15 Integrin {alpha}4ß7 plays an important role in the homing of activated lymphocytes to PPs and to the intestinal lamina propria.16 ß7 Integrin-deficient (ß7-/-) mice suffer from severely-reduced cellularity of PPs (>90% less B and T cells)17 and from impaired intestinal immunity in a variety of disease models.18-20 With the exception of the GALT, lymphoid organs of ß7-/- mice are otherwise normal. These mice are therefore well-suited to dissect the role of mucosa-associated immune tissue, including B cells, in the pathogenesis of enterically-initiated prion disease.

In addition, B lymphocytes exert an important organogenic role in the GALT21,22 and are likely to be involved in the B cell-dependent development of the follicle-associated epithelium (FAE).23 However, splenic lymphocytes can acquire prion infectivity,24 and it is unclear whether their role in prion pathogenesis is restricted to the generation and maintenance of FDCs13 or whether they may also be involved in prion trafficking.25 To dissect the organogenetic effects from trafficking components, we administered prions orally to TNF{alpha}-/-/LT{alpha}-/- mice, which have normal lymphocyte counts but lack the two cytokines TNF-{alpha} and LT{alpha},26 to B cell-deficient µMT mice,27 and to RAG-1-/- mice28 which lack all T and B lymphocytes. While there were no recognizable PPs in TNF{alpha}-/-/LT{alpha}-/- mice, unexpectedly we found that µMT and RAG-1-/- mice had some FDC-M1-positive cells in their atrophic Peyer’s patches, but not in spleen nor in lymph nodes. However, these FDC-like structures were not sufficient for enteric prion replication.

Here we show that prion replication in the GALT and subsequent neuroinvasion was independent of B cells within the mucosa-associated lymphatic tissue and that the remaining M cells are most likely important for this process. TNF{alpha}-/-/LT{alpha}-/-, µMT, and RAG-1-/- mice were highly resistant to oral challenge, and their intestines were virtually devoid of prion infectivity at all times after challenge. Therefore, lymphoreticular requirements for enteric and intraperitoneal uptake of prions differ, and the presence of intramucosal B lymphocytes does not appear to be important for prion pathogenesis following oral challenge.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Animals

C57BL/6, Sv129 x BL/6, µMT,27 RAG-1-/-,28 and TNF{alpha}-/-/LT{alpha}-/-26 mice were bred at the Institute of Laboratory Animal Science of the University of Zurich and maintained under specific pathogen-free conditions. Wild-type mice were obtained originally from the Jackson Laboratory, Bar Harbor, ME.

Alkaline Phosphatase Detection

For detection of alkaline phosphatase (AP) activity, fixed whole PPs were studied. Segments of the small intestine containing one PP were excised, opened, and pinned on dental wax. Tissues were fixed for 10 minutes in Baker formalin calcium medium (pH 6) on ice. At this stage, villi were removed using a binocular microscope, and incubated with 125 nmol/L Tris buffer (pH 9.2) at 37°C for 5 minutes and then incubated in Tris buffer containing naphthol AS-BI phosphate (Sigma, Deisenhofen, Germany) with constant shaking for 10 minutes. The reaction was stopped with ice-cold buffer. Goblet cells were detected by incubating tissue briefly in 1% Alcian blue dissolved in 3% acetic acid. Whole-mount FAEs were then used to enumerate AP-negative M cells as a percentage of the total cell population within the FAE. Statistical significance was determined using the unpaired Student’s t-test. Values of P < 0.05 were considered as significant.

Challenge with Scrapie Prions

Mice were fed with logarithmic dilutions of 10% heat- and sarcosyl-treated brain homogenate prepared from mice infected with the Rocky Mountain Laboratory (RML) scrapie strain (passage 4.1). 8 log LD50 of the prion homogenate RML were administered via gastrolavage directly into the stomach. Smaller amounts (see Table 1 ) were administered by feeding a mixture of brain homogenate with food pellets. For intraperitoneal inoculations, 6 log LD50 of scrapie inoculum was administered. Mice were monitored on alternate days, and scrapie was diagnosed according to standard clinical criteria.


View this table:
[in this window]
[in a new window]
 
Table 1. Susceptibility of Mice with Different Alterations of the Gut-Associated Lymphoid Tissue to Scrapie

 
Infectivity Bioassay

Bioassays were performed on 1% homogenates of spleens or of PBS-perfused small intestines (containing Peyer’s patches). Tissues were homogenized in PBS/BSA with a microhomogenizer and passed several times through 18-gauge and 22-gauge needles. Following preparation of a homogeneous suspension, centrifugation was performed at 500 x g for 5 minutes. Supernatants (30 µl) were inoculated intracerebrally into groups of at least four tga20 mice.29 The titer of the standard inoculum (7.9 log 10 of 50% lethal dose (LD50)/ml, corresponding to 8.9 log LD50/g of brain tissue) was determined by the 50% endpoint calculation method.30 The relationship y = 11.45 - 0.088 (y, log LD50 x ml-1 of homogenate; x, incubation time in days to terminal disease) was calculated by linear regression.25,31 Indicator mice were sacrificed after development of terminal scrapie and infectivity titers were calculated.

Histology and Immunohistochemistry

Paraffin sections (2 µm) and cryostat sections (10 µm) from brain, spleen and PPs were stained with hematoxylin and eosin. Immunostaining for GFAP was performed using rabbit GFAP antisera (1:300 dilution; DAKO, Carpinteria, CA) and detected with biotinylated swine anti-rabbit serum (1:250 dilution; DAKO), avidin-peroxidase and diaminobenzidine (Sigma). Antibodies reactive against the follicular dendritic cell marker FDC-M1 (clone 4C11; 1:300 dilution) or the pan-B cell marker CD45R/B220 (BD Pharmingen, San Diego, CA) were used for immunohistochemistry of frozen sections as previously described.32

Western Blot Analysis

Tissue homogenates were adjusted to protein concentrations of 5 mg/ml (brain) or 8 mg/ml (spleen) and treated with proteinase K (20 µg/ml, 30 minutes, 37°C). 50 µg (brain) or 80 µg (spleen) of total protein of each sample were electrophoresed through a 12% SDS-PAGE gel. Proteins were transferred to nitrocellulose membranes by semi-dry blotting. Membranes were blocked with Tris-buffered saline containing 0.1% Tween 20, pH 8.0 (TBST)/5% nonfat milk, incubated with antibodies 6H4 (for brain protein) or 1B3 (for spleen protein), and detected using alkaline phosphatase-linked anti-mouse (6H4) or anti-rabbit (1B3) sera followed by development by enhanced chemiluminescence (ECL; Amersham, Uppsala, Sweden).


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Normal Numbers of PPs in ß7-/- Mice

To evaluate the extent to which the absence of {alpha}4ß7 integrin, TNF/lymphotoxin, and B and T cells affects the presence of PPs, mice were examined anatomically. PPs of wild-type mice of the C57BL/6 and 129SvxBL6 genetic background were easily visible to the naked eye, whereas in ß7-/-, RAG-1-/-, and µMT mice PPs were undetectable by gross inspection. However, when small intestines were inflated with saline buffer (PBS) and transilluminated under a dissecting microscope (16x magnification), numerous small Peyer’s patches could be discerned (Figure 1) . The number and location (data not shown) of Peyer’s patches in ß7-/- mice (n = 6–10, mean 8.0 ± 1.5) were similar to wild-type mice (n = 6–11, mean 7.3 ± 1.5). A comparison with Student’s t-test, however, yielded a P value of >0.05, indicating that the number of Peyer’s patches in the two groups was not significantly different. In contrast, the number of PPs in B cell-deficient µMT mice were significantly reduced (0–7, mean 2.5 ± 2.2; P < 0.01 if compared to the respective wild-type control). Combined B cell and T cell deficiency in RAG-1-/- mice further reduced the number of PPs (0–5, mean 2.0 ± 1.7; P < 0.01). The absence of TNF-{alpha} and lymphotoxin-{alpha} (LT{alpha}) completely prevented the formation of visible Peyer’s patches (P < 0.01).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 1. Number of Peyer’s patches in mice of various immunodeficient genotypes. Peyer’s patches were counted using stereo microscopical transillumination (magnification, x16) of the small intestine after filling with PBS. The box and whiskers plot shows range and quartiles. The box extends from the 25th to the 75th percentile, with a line at the median (the 50th percentile). The whiskers extend above and below the box to show the highest and lowest values.

 
The size of the M cell-containing subepithelial domes of ß7-deficient mice were reduced by at least 70% compared to those of wild-type mice (approximately 250 µm versus up to 800 µm for full length of equatorial sections). A similar reduction in the size of FAE was found in B cell-deficient PPs of RAG-1-/- and µMT mice.

Peyer’s Patches of ß7-/-, RAG-1-/-, and µMT Mice Are Atrophic but Contain FDCs

To determine whether the absence of {alpha}4ß7 integrin and lymphocytes alters the cellular composition of secondary lymphoid organs, we studied spleen and PPs by immunohistochemistry using antisera reactive against the B lymphocyte marker B220 and with the FDC marker M1 (Figure 2) . The germinal center histology of spleens of ß7-/- mice was indistinguishable from wild-type spleens. B cell zones were distinct and contained FDC-M1-positive cells of normal shape and localization.



View larger version (88K):
[in this window]
[in a new window]
 
Figure 2. Morphological appearance of Peyer’s patches and spleens in ß7-/-, RAG-1-/-, µMT, TNF{alpha}-/-x LT{alpha}-/- and wild-type mice. The atrophic Peyer’s patches found in ß7-/- mice contained an almost complete absence of B cells (B220) compared to wild-type mice and a reduced FDC network within Peyer’s patches. Instead, there was a normal composition of B cell follicles and FDC networks in spleens of ß7-/- mice. The microarchitecture of spleen and Peyer’s patches in RAG-1-/- and µMT mice was severely impaired. However, B220 staining revealed single positive cells in RAG-1-/- and µMT tissues, these most likely being NK cells (see Results). Surprisingly, positive staining with the FDC marker M1 was observed in the Peyer’s patches (but not spleens) of these mice. In the case of TNF{alpha}-/- x LT{alpha}-/- mice a portion of the small intestine was stained. Original magnifications, x100 and x200 for B220 staining and FDC-M1, respectively.

 
In wild-type PPs, FDC networks occupied large regions of the germinal centers. Although there was a significant reduction in the number of B cells in ß7-/- PPs, some FDCs were still detectable. In contrast, no PPs were observed in TNF-{alpha}/LT{alpha}-deficient mice, although a small number of B cells were still present in the small intestine of these mice. Lymphoid organ structure of spleens of TNF-{alpha}/LT{alpha}-deficient mice was severely impaired, without any separation between T and B cell zones, and FDCs were undetectable.

No FDC-M1 positive cells were detected in the spleens of RAG-1-/- and µMT mice, in agreement with earlier reports.22 Unexpectedly, clusters of cells reactive with FDC-M1 and CD35 (CR1, not shown) were consistently detected in the small atrophic Peyer’s patches of RAG-1-/- and µMT mice. Immunostaining also revealed a number of B220 positive cells in spleens and PPs. The majority of these B220-positive cells are most likely NK cells, because the antibody used (CD45R/B220) reacts with an epitope on the extracellular domain of the CD45 glycoprotein, which is expressed on lytically active subsets of lymphokine-activated killer cells such as NK cells and their progenitors in addition to B lymphocytes.33 The smaller B220+ cell population in the PPs of RAG-1-/- and µMT mice most likely consist of immature B cells which are still able to produce functional immunoglobulins of the A class even in the absence of surface, membrane-bound IgM or IgD, therefore representing a developmental pro-B cell block in these strains.34

ß7-/- Intestinal Epithelium Contains M Cells Despite Depleted Intraepithelial B Cells

M cells of the FAE are believed to be important antigen sampling sites, and can act as entry sites for pathogens. To determine whether the absence or reduction of lymphocytes alters the composition of the FAE, we performed immunostaining of PPs of wild-type, ß7-/-, RAG-1-/- and µMT with antibodies reactive against specific markers for M cells (Figure 3, A–D) . M cells, visualized histochemically by their reduced AP activity,35 were readily detectable in the FAE of wild-type mice (Figure 3A) . In ß7-/-, µMT, and RAG-1-/- (Figure 3, B, C, and D , respectively), both PPs and AP-negative M cells were apparent. The presence of PPs and AP-negative M cells was further confirmed by scanning electron microscopy, which allowed visualization of the disorganized brush border of these cells (data not shown).



View larger version (55K):
[in this window]
[in a new window]
 
Figure 3. Presence and distribution of M cells in Peyer’s patches in several B cell-deficient mice. A–D: Enterocytes with high alkaline phosphatase (AP) activity of wild-type (A), ß7-/- (B), µMT (C), and RAG-1-/- (D). Peyer’s patches were stained red, and mature M cells lacking AP activity appeared white. Goblet cells that also lack AP activity were selectively stained in blue using Alcian blue. Some pink cells observed with this technique were considered to represent cells with a phenotype intermediate between mature enterocytes and M cells. Original magnification of all large figures, x100. Insets represent a high-power view (x400) of part of the domes. E: Quantification of intestinal M cells on whole-mount preparation Peyer’s patches stained for AP. Whole mounts were stained as in A–D and AP-negative and AP-positive cells were counted. The abundance of M cells (% of the total epithelial cells within the FAE) was enhanced in B cell-reduced/deficient mice. Values are presented as a box and whiskers plot as in Figure 1 .

 
In contrast to PPs of wild-type mice, in which M cells were located at the periphery of the FAE, the distribution of M cells appeared to be random over the entire surface of FAE in PPs of ß7-/-, RAG-1-/-, and µMT mice.

We then estimated the relative number of intestinal M cells per total epithelial cells within the FAE by counting AP-negative M cells under 400x magnification by light microscopy (Figure 3E) . The relative number of M cells was increased in the FAE of ß7-/- (mean: 15.4 ± 4.0 vs. 6.7 ± 1.8 for 129Sv x BL/6 mice, P < 0.01), RAG-1-/- (mean: 13.5 ± 2.3 vs. 7.2 ± 2.7 for BL/6, P < 0.05) and µMT (mean: 14.2 ± 2.8 compared to BL/6, P < 0.05) tissues. These data indicate that the differentiation program of the FAE, including M cells, is maintained even in the absence of proper B cell numbers.

Unimpaired Scrapie Pathogenesis in ß7-Deficient Mice

To determine the contribution of different components of the GALT to the intestinal uptake of orally-delivered prions, mice were challenged with logarithmic dilutions of scrapie inoculum. Attack rate and time to terminal disease were measured. Following high-dose oral infection (8 log LD50) all ß7-/- mice, Sv129 x C57BL/6 wild-type mice, and 9 of 10 C57BL/6 wild-type mice developed clinical signs of scrapie with similar incubation times of 213 to 230 days (Table 1) . These results indicate that ß7-/- mice are highly susceptible to disease via oral administration of prions. Accordingly, accumulation of PK-resistant PrPSc was readily detectable in brains and spleens of clinically sick ß7-/- and wild-type mice (Figure 4) . Moreover, topography and intensity of spongiosis and gliosis were similar in clinically sick ß7-/- mice compared to clinically sick wild-type mice (Figure 5) . Importantly, the use of lower prion inocula via the oral route significantly decreased the susceptibility to disease in these mice compared to i.p. challenge. A 10-fold dilution of the scrapie inoculum reduced the scrapie attack rate to 50% in ß7-/- and to 50 to 25% in the different wild-type mice. Further dilution of the inoculum did not evoke scrapie in mice of any genotype.



View larger version (40K):
[in this window]
[in a new window]
 
Figure 4. Western blot analysis of brains and spleens. Presence or absence of PrPSc was determined by western blots of spleen or brain material electrophoresed natively (-), or after digestion with PK (+). Molecular weights of the proteins were indicated in kilodaltons on the left. Large amounts of PrPSc were detected in the brains and spleens of either ß7-/- or wild-type mice that had developed scrapie (terminal sick) after the time points indicated. PrPSc was detected only in mice which were challenged orally with high-dose (8 log LD50) RML or i.p. with 6 log LD50 but not in tissues of clinically healthy mice, thereby excluding subclinical disease.

 


View larger version (48K):
[in this window]
[in a new window]
 
Figure 5. Morphological changes in the brains of mice orally exposed to prions. Pronounced astrogliosis (GFAP) in the hippocampus of scrapie-sick (terminal disease) ß7-/- and wild-type mice was obvious, whereas no gliosis and vacuolization (H&E) was observed in clinically healthy RAG-1-/-, µMT, and TNF{alpha}-/- x LT{alpha}-/- mice. Original magnification, x200.

 
After i.p. prion challenge (6 log LD50) ß7-/- and wild-type mice had similar incubation times of 210 to 217 days, indicating normal peripheral prion pathogenesis. As described earlier,8,14 B cell-deficient RAG-1 and µMT mice were completely resistant, and TNF{alpha}-/-/LT{alpha}-/- mice partially resistant, to prions administered i.p. Wild-type mice can be experimentally infected via the i.p. route with prion inocula of less than 3 intracerebral log LD50, yet the minimal dose for oral infection is 7 intracerebral log LD50 of scrapie inoculum. Therefore, these results confirm previous observations that the oral route of prion infection is relatively inefficient in mice.

In contrast to wild-type or ß7-/- animals, mice deficient for LT{alpha} and TNF-{alpha} and mice lacking mature B cells were virtually resistant to orally-administered prions, even when extremely large inocula were used. This provides evidence that neither small intestines from TNF{alpha}-/- x LT{alpha}-/- mice nor atrophic PPs of RAG-1-/- and µMT mice are sufficient as entry sites of prions.

Although PPs of the small intestine are potential entry sites for pathogens, draining lymph nodes and the spleen provide lymphoid sites with a mechanism for pathogen clearance. However, RAG-1-/-, µMT, and TNF{alpha}-/- x LT{alpha}-/- mice were highly resistant to i.p. infection with prions (Table 1) ,8 and therefore the phase of peripheral prion replication is also impaired in these mice. Accordingly, PrPSc was undetectable in brains and spleens of clinically healthy RAG-1-/-, µMT, and TNF{alpha}-/- x LT{alpha}-/- mice at the indicated postinfection time points.

Peyer’s Patches of ß7-/- but Not RAG-1-/- and µMT Mice Are Sites of Peripheral Prion Replication

We then investigated peripheral prion replication in PPs and spleens of ß7-/-, RAG-1-/-, and µMT mice following oral challenge. PPs (Figure 6 , red symbols) and spleens (Figure 6 , blue symbols) were collected at various time points after oral (8 log LD50) or i.p. (6 log LD50) infection until terminal disease. Infectivity titers were determined by transmission of homogenized tissues to indicator mice. For those TNF{alpha}-/- x LT{alpha}-/- mice which lacked all PPs, selected portions of the small intestine were dissected and used for transmission studies.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 6. Determination of prion infectivity titers in spleens, Peyer’s patches, or small intestines of scrapie-challenged mice with different alterations in the GALT. Titers were determined in spleens (blue symbols) and Peyer’s patches (red symbols) of wild-type (crosses), ß7-/-(circles), RAG-1-/ (diamonds), µMT (squares) and TNF{alpha}-/- x LT{alpha}-/- (triangles) mice. Since TNF{alpha}-/- x LT{alpha}-/- mice lacked PPs, segments of the small intestine were processed for transmission studies to indicator mice. Mice were challenged orally with 8 log LD50 or i.p. with 6 log LD50 of scrapie prions as indicated. Standard deviations within groups are presented only when they exceed ± 0.75 log LD50. Symbols on the abscissa and below the threshold of the prion titer 1.5 log LD50 indicate prion titers below detection limit (none of the four indicator mice developed scrapie). If one or more indicator mice survived >180 dpi, or if the mean incubation time was more than 120 days, titer was assumed to be close to the detection threshold of the bioassay at prion titer of 1.5 log LD50. For these samples (labeled with small letters) the numbers of animals succumbing to scrapie out of four inoculated tga20 mice and incubation time (in days) to terminal scrapie were as follows: a, 2/4(87,117); b, 2/4(109,111); c, 1/4(92); e, 2/4(117,134); f, 1/4(109), g, 3/4(124,134,151). d: In this transmission experiment one of the four tga20 mice died 24 hours after inoculation, most likely as a result of intracerebral bleeding following the injection procedure.

 
Infectivity titers in spleens of wild-type (crosses) and ß7-/- mice (circles) after oral challenge were generally determined to be lower than after intraperitoneal challenge. Additionally, the kinetics of prion replication differed in PPs and spleens after oral and i.p. challenge. Following i.p. inoculation, high titers of infectivity were already present at approximately 50 dpi in both genotypes, whereas following oral challenge, infectivity was only detected at 110 days.

With the exception of trace levels of infectivity in spleens and PPs of RAG-1-/- and TNF{alpha}-/- x LT{alpha}-/- mice at latter time points, we found no evidence for infectivity in any spleen and PP of challenged RAG-1-/- (diamonds), µMT (squares), and TNF{alpha}-/- x LT{alpha}-/- (triangles) mice. Therefore, the absence of PPs in mice deficient in TNF-{alpha} and LT{alpha} prevents gastroenteric invasion of prions.

Even more surprisingly, PPs of RAG-1-/- and µMT mice were devoid of infectivity despite the presence of FDC-M1-positive cell cluster (Figure 2) . As previously mentioned, it is probable that these cells are FDC-like since they are CD35-positive and have also been reported to be dependent on LTß signaling.21 However, it is not obvious whether these cells represent functionally inactive FDCs. The data presented here appear to suggest that ablation of mature B cells, which are the primary sources of LT{alpha} and LTß, abolishes the induction of FDC-M1-positive cells in the spleen, but not in PPs.


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The mechanisms associated with the enteric trafficking of prions following oral infection are poorly understood. Here we have investigated the role of various components of the enteric mucosal immune system in the pathogenesis of scrapie on oral administration of prions. The oral route of prion infection is much less efficient than the intraperitoneal route. In the present series of experiments, we were able to infect wild-type and {alpha}4ß7-/- mice with prion inocula of less than 3 log LD50 via the i.p. route. In contrast, the minimal dose for infection via the oral route was 7 log LD50 of scrapie inoculum. This indicates that the intestinal mucosa constitutes an effective barrier for prions. This may be due to potential antiprion effects of mucosal immunity, or because transepithelial prion transport is rate-limiting.

Our data appear to indicate that proper homing of B lymphocytes to the enteric mucosa is not a compulsory prerequisite for enteric prion uptake. This finding is surprising, since B cells are crucially important for peritoneal prion pathogenesis,8 and {alpha}4ß7-/- mice with marked reduction of enteric lymphocytes display significant alterations in various models of intestinal inflammation and infection.18,19,20

The GALT consists of highly-organized PPs in the small intestine, and intraepithelial lymphocytes are present throughout the length of the gastrointestinal tract. The intestinal surfaces of PPs are characterized by the presence of "domes," which are regions free of intestinal villi.36 At these domes, M cells are able to tunnel pathogens through the cytoplasm to the basal surface, where deep invaginations of their membrane allow close contact with lymphocytes and macrophages.37

Surprisingly, we found no evidence of scrapie infectivity in the atrophic PPs of B cell-deficient µMT and RAG-1-/- mice orally challenged with prions, despite the presence of M cells in these mice.21,22 We estimated that the number of M cells in B cell deficient mice was approximately 150 to 840 times less than in wild-type mice.22 It is possible that this reduction in M cell numbers also leads to strong functional impairment, such that sufficient prion replication in B cell-deficient mice may no longer be possible. In view of the presence of FDC-M1-positive cells within PPs of µMT and RAG-1-/- mice, the absence of detectable prion infectivity in PPs of these mice is also surprising, since mature B cells are believed to be required to support FDC maturation in adult peripheral lymphoid tissues.38 Whether these FDC-M1-positive cells represent mature FDCs, precursors of FDCs, or an unrelated cell type remains to be established. However, it should be noted that we have been able to determine that these cells are also CD35 (CR1) positive (data not shown) and are highly sensitive to LTßR-Ig fusion protein treatment,21 indicating that they share several features in common with splenic FDCs. Importantly, we were unable to detect cells reactive for FDC markers in spleens or lymph nodes of µMT and RAG-1-/- mice (data not shown).

Three major cell types are known to express LT{alpha}ß for the induction of FDCs in adult mice: T, B, and NK cells. NK cells are the only LT{alpha}ß+ cells retained in µMT and RAG-1-/- mice. It is conceivable that these cells may supply the LT{alpha}ß signals and indeed, LT{alpha}ß+CD4+CD3- cell populations have been observed in developing Peyer’s patches.39

The relatively high resistance of B cell-deficient mice to oral prion challenge is in agreement with our earlier observations that following i.p. inoculation, RAG-1-/-, RAG-2-/-, and µMT mice failed to establish prion replication in the spleen and did not develop scrapie for >600 days.8 However although accumulation of PrPSc has been observed in the brains of some B cell-deficient mice,40 we found no cases of subclinical disease on oral administration of prions, as assessed by Western blot analysis of brain homogenates.

As described repeatedly,8,14,25 B cell-deficient mice were entirely resistant to i.p. administered prions, while TNF/LT deficient mice were partially resistant. These findings differ from those reported by Mabbott et al41 and suggest that the importance of B lymphocytes in prion pathogenesis might go beyond their role in FDC maintenance.

The data outlined here indicate that the requirements for oral and i.p. pathogenesis differ profoundly. The significant reduction of mucosal lymphocytes seen in ß7-/- mice is not limiting for oral prion uptake. FDCs are unlikely to be rate limiting, since there was a marked reduction in number of these cells in sensitive ß7-/- mice, and they were not completely abolished in fully protected RAG-1-/- and µMT mice. Instead, absolute resistance to oral prion infection was achieved here if Peyer’s patches or B cells were totally absent.

It is unclear which elements, lacking from RAG-1-/- and µMT mice, are necessary for pathogenesis following oral prion challenge in ß7-/- mice. Epithelial M cells are certainly plausible candidates, since they efficiently transcytose prion infectivity from the apical to the basolateral compartment in an in vitro co-culture system.42 M cells are still present in RAG-1-/- mice, but their functionality is dependent on the presence of mature B cells,22 which are still present in small numbers in ß7-/- mice. Since there is a lack of isolated M cell-specific genes, it is not yet possible to address this directly in vivo, for example, by using transgenesis and lineage ablation strategies.

The findings reported here indicate that the pathophysiology of prion infection after oral uptake relies on mechanisms and cellular components significantly different from the established requirements for the intraperitoneal route (lymphocytes, FDCs). Clearer understanding of the process involved in mucosal passage of prions will be crucial in dealing effectively with orally-transmitted prion diseases, such as bovine spongiform encephalopathy, vCJD, and chronic wasting disease.


    Acknowledgements
 
The authors thank Petra Schwarz, Grazia Maria D‘Angelo, and Denis Marino for assistance with experiments, Nathalie Debard and Jean-Pierre Kraehenbuhl for teaching us whole-mount PP M cell-staining techniques, and Gino Miele for critical reading of the manuscript.


    Footnotes
 
Address reprint requests to Adriano Aguzzi, Institute of Neuropathology, University Hospital of Zürich, Schmelzbergstrasse 12, CH-8091 Zürich, Switzerland. E-mail: adriano{at}pathol.unizh.ch

Supported by grants from the Bundesamt für Bildung und Wissenschaft, the Migros Foundation, the National Center for Competence in Research on Neural Plasticity and Repair, and the Swiss National Foundation (A.A.). M.P. was a postdoctoral fellow of the Deutsche Forschungsgemeinschaft (Pr 577/2–1), F.L.H. is supported by the Stammbach foundation, and M.G. is supported by the Forschungskredit der Universität Zürich.

Accepted for publication December 18, 2002.


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ: Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 1997, 389:498-501[Medline]
  2. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P: The same prion strain causes vCJD and BSE (letter). Nature 1997, 389:448-450[Medline]
  3. Aguzzi A, Montrasio F, Kaeser PS: Prions: health scare and biological challenge. Nat Rev Mol Cell Biol 2001, 2:118-126[Medline]
  4. Beekes M, McBride PA: Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci Lett 2000, 278:181-184[Medline]
  5. Kimberlin RH, Walker CA: Pathogenesis of scrapie in mice after intragastric infection. Virus Res 1989, 12:213-220[Medline]
  6. Bons N, Mestre-Frances N, Belli P, Cathala F, Gajdusek DC, Brown P: Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci USA 1999, 96:4046-4051[Abstract/Free Full Text]
  7. Foster JD, Parnham DW, Hunter N, Bruce M: Distribution of the prion protein in sheep terminally affected with BSE following experimental oral transmission. J Gen Virol 2001, 82:2319-2326[Abstract/Free Full Text]
  8. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, Bootz F, Suter M, Zinkernagel RM, Aguzzi A: A crucial role for B cells in neuroinvasive scrapie. Nature 1997, 390:687-690[Medline]
  9. Fu YX, Chaplin DD: Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 1999, 17:399-433[Medline]
  10. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, Frosh A, Tolley N, Bell JE, Spencer M, King A, Al-Sarraj S, Ironside JW, Lantos PL, Collinge J: Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999, 353:183-189[Medline]
  11. Brown KL, Stewart K, Ritchie DL, Mabbott NA, Williams A, Fraser H, Morrison WI, Bruce ME: Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat Med 1999, 5:1308-1312[Medline]
  12. Mabbott NA, Mackay F, Minns F, Bruce ME: Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie (letter). Nat Med 2000, 6:719-720[Medline]
  13. Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, Aguzzi A, Weissmann C: Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 2000, 288:1257-1259[Abstract/Free Full Text]
  14. Prinz M, Montrasio F, Klein MA, Schwarz P, Priller J, Odermatt B, Pfeffer K, Aguzzi A: Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc Natl Acad Sci USA 2002, 99:919-924[Abstract/Free Full Text]
  15. Butcher EC, Williams M, Youngman K, Rott L, Briskin M: Lymphocyte trafficking and regional immunity. Adv Immunol 1999, 72:209-253[Medline]
  16. Hamann A, Andrew DP, Jablonski-Westrich D, Holzmann B, Butcher EC: Role of {alpha}4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 1994, 152:3282-3293[Abstract]
  17. Wagner N, Lohler J, Kunkel EJ, Ley K, Leung E, Krissansen G, Rajewsky K, Muller W: Critical role for ß7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996, 382:366-370[Medline]
  18. Artis D, Humphreys NE, Potten CS, Wagner N, Muller W, McDermott JR, Grencis RK, Else KJ: ß7 integrin-deficient mice: delayed leukocyte recruitment and attenuated protective immunity in the small intestine during enteric helminth infection. Eur J Immunol 2000, 30:1656-1664[Medline]
  19. Kuklin NA, Rott L, Darling J, Campbell JJ, Franco M, Feng N, Muller W, Wagner N, Altman J, Butcher EC, Greenberg HB: {alpha}(4)ß(7) independent pathway for CD8(+) T cell-mediated intestinal immunity to rotavirus. J Clin Invest 2000, 106:1541-1552[Medline]
  20. Lefrancois L, Parker CM, Olson S, Muller W, Wagner N, Schon MP, Puddington L: The role of ß7 integrins in CD8 T cell trafficking during an antiviral immune response. J Exp Med 1999, 189:1631-1638[Abstract/Free Full Text]
  21. Debard N, Sierro F, Browning J, Kraehenbuhl JP: Effect of mature lymphocytes and lymphotoxin on the development of the follicle-associated epithelium and M cells in mouse Peyer’s patches. Gastroenterology 2001, 120:1173-1182[Medline]
  22. Golovkina TV, Shlomchik M, Hannum L, Chervonsky A: Organogenic role of B lymphocytes in mucosal immunity. Science 1999, 286:1965-1968[Abstract/Free Full Text]
  23. Wu Q, Wang Y, Wang J, Hedgeman EO, Browning JL, Fu YX: The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J Exp Med 1999, 190:629-638[Abstract/Free Full Text]
  24. Raeber AJ, Klein MA, Frigg R, Flechsig E, Aguzzi A, Weissmann C: PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice. EMBO J 1999, 18:2702-2706[Medline]
  25. Kaeser PS, Klein MA, Schwarz P, Aguzzi A: Efficient lymphoreticular prion propagation requires prp(c) in stromal and hematopoietic cells. J Virol 2001, 75:7097-7106[Abstract/Free Full Text]
  26. Eugster HP, Muller M, Karrer U, Car BD, Schnyder B, Eng VM, Woerly G, Le Hir M, di Padova F, Aguet M, Zinkernagel R, Bluethmann H, Ryffel B: Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-{alpha} double-deficient mice. Int Immunol 1996, 8:23-36[Abstract/Free Full Text]
  27. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin µ chain gene. Nature 1991, 350:423-426[Medline]
  28. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877[Medline]
  29. Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C: Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 1996, 15:1255-1264[Medline]
  30. Reed J, Muench H: A simple method of estimating 50% endpoints. Am J Hygiene 1938, 27:493-497
  31. Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM: Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 1982, 11:353-358[Medline]
  32. Karrer U, Lopez-Macias C, Oxenius A, Odermatt B, Bachmann MF, Kalinke U, Bluethmann H, Hengartner H, Zinkernagel RM: Antiviral Bcell memory in the absence of mature follicular dendritic cell networks and classical germinal centers in TNFR1-/- mice. J Immunol 2000, 164:768-778[Abstract/Free Full Text]
  33. Rolink A, ten Boekel E, Melchers F, Fearon DT, Krop I, Andersson J: A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J Exp Med 1996, 183:187-194[Abstract/Free Full Text]
  34. Macpherson AJ, Lamarre A, McCoy K, Harriman GR, Odermatt B, Dougan G, Hengartner H, Zinkernagel RM: IgA production without µ or {delta} chain expression in developing B cells. Nat Immunol 2001, 2:625-631[Medline]
  35. Brown D, Cremaschi D, James PS, Rossetti C, Smith MW: Brush-border membrane alkaline phosphatase activity in mouse Peyer’s patch follicle-associated enterocytes. J Physiol 1990, 427:81-88[Abstract/Free Full Text]
  36. Bockman DE, Cooper MD: Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer’s patches: an electron microscopic study. Am J Anat 1973, 136:455-477[Medline]
  37. Sansonetti PJ, Phalipon A: M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. Semin Immunol 1999, 11:193-203[Medline]
  38. Endres R, Alimzhanov MB, Plitz T, Futterer A, Kosco-Vilbois MH, Nedospasov SA, Rajewsky K, Pfeffer K: Mature follicular dendritic cell networks depend on expression of lymphotoxin ß receptor by radioresistant stromal cells and of lymphotoxin ß and tumor necrosis factor by B cells. J Exp Med 1999, 189:159-168[Abstract/Free Full Text]
  39. Yoshida H, Honda K, Shinkura R, Adachi S, Nishikawa S, Maki K, Ikuta K, Nishikawa SI: IL-7 receptor {alpha}+ CD3(-) cells in the embryonic intestine induces the organizing center of Peyer’s patches. Int Immunol 1999, 11:643-655[Abstract/Free Full Text]
  40. Frigg R, Klein MA, Hegyi I, Zinkernagel RM, Aguzzi A: Scrapie pathogenesis in subclinically infected B cell-deficient mice. J Virol 1999, 73:9584-9588[Abstract/Free Full Text]
  41. Mabbott NA, Williams A, Farquhar CF, Pasparakis M, Kollias G, Bruce ME: Tumor necrosis factor {alpha}-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol 2000, 74:3338-3344[Abstract/Free Full Text]
  42. Heppner FL, Christ AD, Klein MA, Prinz M, Fried M, Kraehenbuhl JP, Aguzzi A: Transepithelial prion transport by M cells. Nat Med 2001, 7:976-977[Medline]



This article has been cited by other articles:


Home page
J. Virol.Home page
S. Cordier-Dirikoc and J. Chabry
Temporary Depletion of CD11c+ Dendritic Cells Delays Lymphoinvasion after Intraperitonal Scrapie Infection
J. Virol., September 1, 2008; 82(17): 8933 - 8936.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Kanaya, K. Miyazawa, I. Takakura, W. Itani, K. Watanabe, S. Ohwada, H. Kitazawa, M. T. Rose, H. R. McConochie, H. Okano, et al.
Differentiation of a murine intestinal epithelial cell line (MIE) toward the M cell lineage
Am J Physiol Gastrointest Liver Physiol, August 1, 2008; 295(2): G273 - G284.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. R. Raymond, P. Aucouturier, and N. A. Mabbott
In Vivo Depletion of CD11c+ Cells Impairs Scrapie Agent Neuroinvasion from the Intestine
J. Immunol., December 1, 2007; 179(11): 7758 - 7766.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Friedman-Levi, H. Ovadia, R. Hoftberger, O. Einstein, O. Abramsky, H. Budka, and R. Gabizon
Fatal Neurological Disease in Scrapie-Infected Mice Induced for Experimental Autoimmune Encephalomyelitis
J. Virol., September 15, 2007; 81(18): 9942 - 9949.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sethi, K. M. Kerksiek, T. Brocker, and H. Kretzschmar
Role of the CD8+ Dendritic Cell Subset in Transmission of Prions
J. Virol., May 1, 2007; 81(9): 4877 - 4880.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. R. Glaysher and N. A. Mabbott
Role of the GALT in Scrapie Agent Neuroinvasion from the Intestine
J. Immunol., March 15, 2007; 178(6): 3757 - 3766.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. C. Angers, S. R. Browning, T. S. Seward, C. J. Sigurdson, M. W. Miller, E. A. Hoover, and G. C. Telling
Prions in Skeletal Muscles of Deer with Chronic Wasting Disease
Science, February 24, 2006; 311(5764): 1117 - 1117.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. S. Mishra, S. Basu, Y. Gu, X. Luo, W.-Q. Zou, R. Mishra, R. Li, S. G. Chen, P. Gambetti, H. Fujioka, et al.
Protease-Resistant Human Prion Protein and Ferritin Are Cotransported across Caco-2 Epithelial Cells: Implications for Species Barrier in Prion Uptake from the Intestine
J. Neurosci., December 15, 2004; 24(50): 11280 - 11290.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Z. Marcos, K. Pffeifer, M. E. Bodegas, M. P. Sesma, and L. Guembe
Cellular Prion Protein Is Expressed in a Subset of Neuroendocrine Cells of the Rat Gastrointestinal Tract
J. Histochem. Cytochem., October 1, 2004; 52(10): 1357 - 1365.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
A. Aguzzi, F. L Heppner, M. Heikenwalder, M. Prinz, K. Mertz, H. Seeger, and M. Glatzel
Immune system and peripheral nerves in propagation of prions to CNS
Br. Med. Bull., June 1, 2003; 66(1): 141 - 159.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prinz, M.
Right arrow Articles by Aguzzi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prinz, M.
Right arrow Articles by Aguzzi, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS